文献速递前列腺癌

种族对局限性前列腺癌男性治疗模式及后续健康相关生活质量结局的影响

The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2022-11-10

该研究比较了非裔美国(AA)与非AA男性在接受主动监测(AS)、根治性前列腺切除术(RP)或放疗(XRT)时的治疗模式及健康相关生活质量(HRQoL)。AA低危患者较少接受AS、更多接受XRT,中危患者更多接受XRT而较少接受RP;RP后AA男性性困扰更差,XRT对肠道症状的影响在非AA男性中更差。

要点

  • 低危AA男性接受AS的比例为28.5%,低于非AA的38.8%;接受XRT的比例为22.3%,高于非AA的10.6%,p < 0.001。
  • 中危AA男性接受XRT的比例为43.0%,高于非AA的26.9%;接受RP的比例为50.5%,低于非AA的66.8%,p = 0.016。
  • RP后AA男性性困扰评分较非AA更差(p = 0.024);XRT对肠道HRQoL的不良影响仅见于非AA男性。

核心结论

  • AA男性低危疾病较少接受AS,更多接受XRT;RP后AA男性性困扰更差;XRT对肠道症状的影响在非AA男性中更差。

研究设计与样本

  • 研究纳入2007—2017年在前列腺疾病研究中心数据库确诊为前列腺癌的男性,共1006例局限性前列腺癌患者,其中AA 223例(22.2%),平均随访5.2年。
  • HRQoL采用扩展前列腺癌指数复合量表(Expanded PCa Index Composite)和SF-36健康调查评估。

主要发现

  • 低危疾病中,AA男性接受AS的比例为28.5%,低于非AA的38.8%;接受XRT的比例为22.3%,高于非AA的10.6%,p < 0.001。
  • 中危疾病中,AA男性接受XRT的比例为43.0%,高于非AA的26.9%;接受RP的比例为50.5%,低于非AA的66.8%,p = 0.016。
  • 在所有男性中,RP导致泌尿功能和性HRQoL较AS和XRT更差。
  • AA男性中肠道HRQoL不因治疗方式而异;非AA男性中,XRT导致肠道评分较AS和RP更差。
  • RP后AA男性性困扰较非AA男性更差(p = 0.024);接受AS、RP或XRT的男性在泌尿、肠道、激素或SF-36评分上未发现种族差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Racial differences in Health-Related Quality of Life (HRQoL) after treatment of prostate cancer (PCa) are not well studied. We compared treatment patterns and HRQoL in African American (AA) and non-AA men undergoing active surveillance (AS), radical prostatectomy (RP), or radiation (XRT). METHODS: Men diagnosed with PCa from 2007-2017 in the Center for Prostate Disease Research Database were identified. HRQoL was evaluated using Expanded PCa Index Composite and SF-36 Health Survey. RESULTS: In 1006 men with localized PCa, 223 (22.2%) were AA (mean follow up 5.2 yrs). AA men with low-risk disease were less likely to undergo AS (28.5 vs. 38.8%) and more likely to undergo XRT (22.3 vs. 10.6%) than non-AA men, p < 0.001. In intermediate-risk disease, AA received more XRT (43.0 vs. 26.9%) and less RP (50.5 vs 66.8%), p = 0.016. In all men, RP resulted in worse urinary function and sexual HRQoL compared to AS and XRT. Bowel HRQoL did not vary by treatment in AA men, however, in non-AA men, XRT resulted in worse bowel scores than AS and RP. HRQoL was then compared for each treatment modality. AA men had worse sexual bother (p = 0.024) after RP than non-AA men, No racial differences were found in urinary, bowel, hormonal, or SF-36 scores for men undergoing AS, RP or XRT. CONCLUSION: AA men are less often treated with AS for low-risk disease and are more likely to undergo XRT. AA men experience worse sexual bother after RP, however, the effect of XRT on bowel symptoms is worse in non-AA men.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Posielski NM, Shanmuga S, Ho O, et al. The effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer. Prostate Cancer Prostatic Dis. 2022. PMID: 36357592. doi:10.1038/s41391-022-00608-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。